tiprankstipranks
Advertisement
Advertisement

CING Stock Latest News

Cingulate price target lowered to $9 from $10 at Roth Capital
The FlyCingulate price target lowered to $9 from $10 at Roth Capital
19d ago
CING
Cingulate publishes peer-reviewed data on CTx-1301 pharmacokinetic profile
PremiumThe Fly
Cingulate publishes peer-reviewed data on CTx-1301 pharmacokinetic profile
1M ago
CING
Cingulate Restructures Leadership, Eliminates Chief Legal Officer
PremiumCompany Announcements
Cingulate Restructures Leadership, Eliminates Chief Legal Officer
2M ago
8K
CING
Cingulate enhances equity plan and updates board leadership
PremiumCompany Announcements
Cingulate enhances equity plan and updates board leadership
2M ago
8K
CING
Cingulate Inc Added to Broad Russell 3000E Index
PremiumCompany Announcements
Cingulate Inc Added to Broad Russell 3000E Index
2M ago
8K
CING
Cingulate Gains Key U.S. Patent for Lead ADHD Drug
PremiumCompany AnnouncementsCingulate Gains Key U.S. Patent for Lead ADHD Drug
3M ago
8K
CING
Cingulate issues patent by USPTO for CTx-1301
Premium
The Fly
Cingulate issues patent by USPTO for CTx-1301
3M ago
CING
Roth sees ‘major silver lining’ in Cingulate complete response letter
Premium
The Fly
Roth sees ‘major silver lining’ in Cingulate complete response letter
3M ago
CING
Naz Rahman Reiterates Buy on Cingulate, Maintains 12‑Month Price Target at $8 Following FDA Manufacturing-Only Setback
PremiumRatings
Naz Rahman Reiterates Buy on Cingulate, Maintains 12‑Month Price Target at $8 Following FDA Manufacturing-Only Setback
3M ago
CING
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
3M ago
IYR
ABTC
Cingulate issued complete response letter for CTx-1301 from FDA
PremiumThe Fly
Cingulate issued complete response letter for CTx-1301 from FDA
3M ago
CING
Cingulate Faces FDA Delay But Maintains ADHD Drug Plans
PremiumCompany Announcements
Cingulate Faces FDA Delay But Maintains ADHD Drug Plans
3M ago
8K
CING
Cingulate Reshapes Board Structure and Leadership Roles
PremiumCompany AnnouncementsCingulate Reshapes Board Structure and Leadership Roles
4M ago
8K
CING
Cingulate price target lowered to $10 from $14 at Roth Capital
Premium
The Fly
Cingulate price target lowered to $10 from $14 at Roth Capital
4M ago
CING
CING Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CING Upcoming Earnings Report: What to Expect?
4M ago
CING
Six new option listings on April 22nd
PremiumThe Fly
Six new option listings on April 22nd
5M ago
CING
NUCL
Cingulate files to sell 4.21M shares of common stock for holders
PremiumThe Fly
Cingulate files to sell 4.21M shares of common stock for holders
5M ago
CING
Cingulate Adds Independent Director Jiang to Board Committees
PremiumCompany Announcements
Cingulate Adds Independent Director Jiang to Board Committees
5M ago
8K
CING
Cingulate Announces ATM Equity Program and Share Issuance
PremiumCompany Announcements
Cingulate Announces ATM Equity Program and Share Issuance
6M ago
8K
CING
Cingulate price target lowered to $14 from $16 at Roth Capital
PremiumThe FlyCingulate price target lowered to $14 from $16 at Roth Capital
6M ago
CING
Cingulate files to sell 3.5M shares of common stock for holders
Premium
The Fly
Cingulate files to sell 3.5M shares of common stock for holders
6M ago
CING
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
Premium
TipRanks Newswire
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
6M ago
CING
OVID

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >